Hospital-Acquired Infection Diagnostics Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET INTRODUCTION

Hospital-Acquired Infection are acquired during hospitalization, or when admitted into a nursing home, rehabilitation facility, outpatient clinic or other clinical setting. These can be acquired from an infected patient, outside environment, or from a staff of that facility.

MARKET DYNAMICS

The Hospital-Acquired Infection Diagnostics market is anticipated to grow in the forecast, owing to the factors such as rise in geriatric population, demand for hospital-acquired infection diagnostics from middle and low-income economies and development of technologically advanced diagnostic products. Nevertheless, decreasing prevalence of nosocomial infections in the developed countries and lack of awareness regarding HAI.

MARKET SCOPE

The "Global Hospital-Acquired Infection Diagnostics Market Analysis to 2031" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of Hospital-Acquired Infection Diagnostics market with detailed market segmentation by Product, Test Type, Application, Infection Type and geography. The global Hospital-Acquired Infection Diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Hospital-Acquired Infection Diagnostics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global Hospital-Acquired Infection Diagnostics market is segmented on the basis of Product, Test Type, Application and Infection Type. Based on Product the market is segmented into Instruments & Reagents and Consumables. Based on Test Type the market is segmented into Molecular Diagnostics, Urinalysis and Immunoassay. Based on Application the market is segmented into Disease Testing and Drug-Resistance Testing. Based on Infection Type the market is segmented into Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site infections, Gastrointestinal Infections, Urinary Tract Infections and Others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Hospital-Acquired Infection Diagnostics market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Hospital-Acquired Infection Diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Hospital-Acquired Infection Diagnostics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Hospital-Acquired Infection Diagnostics market in these regions.

MARKET PLAYERS

The reports cover key developments in the Hospital-Acquired Infection Diagnostics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Hospital-Acquired Infection Diagnostics market are anticipated to lucrative growth opportunities in the future with the rising demand for Hospital-Acquired Infection Diagnostics market in the global market. Below mentioned is the list of few companies engaged in the Hospital-Acquired Infection Diagnostics market.

The report also includes the profiles of Hospital-Acquired Infection Diagnostics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

• BioMerieux
• Abbott Laboratories
• Alere, Inc.
• Roche AG
• Siemens Healthcare
• Becton Dickenson
• Cepheid Inc.
• Thermo Fisher Scientific
• Seegene, Inc.
• Qiagen

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Hospital-Acquired Infection Diagnostics Report Scope